# Antialbuminuric Effects of Valsartan and Lisinopril

> **NCT00171600** · PHASE4 · TERMINATED · sponsor: **Novartis** · enrollment: 54 (actual)

## Conditions studied

- Hypertension
- Early Diabetic Nephropathy

## Interventions

- **DRUG:** VALSARTAN, VALSARTAN PLUS HCTZ, LISINOPRIL, LISINOPRIL PLUS HCTZ

## Key facts

- **NCT ID:** NCT00171600
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171600, "Antialbuminuric Effects of Valsartan and Lisinopril". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00171600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*